Information  X 
Enter a valid email address


  Print          Annual reports

Tuesday 05 April, 2022


Additional Listing

RNS Number : 3666H
05 April 2022

5 April 2022


BP p.l.c.

Share issuance


BP p.l.c. announces that it will issue and allot 165,105,654 ordinary shares in connection with the merger of BP Midstream RTMS LLC with and into BP Midstream Partners LP. The issuance of the new ordinary shares is subject to an application for the admission of those shares to the Official List of the Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange plc ("Admission"). It is expected that Admission will become effective on 6 April 2022.


The number of ordinary shares in issue after this admission will be 20,643,650,955 of which 1,034,433,759 are held as treasury shares leaving a balance of 19,609,217,196 ordinary shares with a par value of US$0.25 per share, each with one vote and 12,706,252 preference shares par value £1 per share with two votes for every £5 in nominal capital held and the total number of voting rights in BP p.l.c. will be 19,614,299,696.


These new ordinary shares will, when issued, be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares of US$0.25 each in BP p.l.c., including the right to receive dividends and other distributions declared, made or paid on or in respect of such shares after the date of issue.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t